These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 16900112)
21. Emergency physician survey: recombinant tissue plasminogen activator for stroke. Mann J Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689 [No Abstract] [Full Text] [Related]
22. Efficacy of cryopreserved recombinant alteplase for declotting thrombosed central catheters. Isaac BF Ann Pharmacother; 2000 Apr; 34(4):533-4. PubMed ID: 10772443 [No Abstract] [Full Text] [Related]
23. [Thrombolysis in central retinal artery occlusion using alteplase]. Mach R; Procházka J Cesk Slov Oftalmol; 2008 Nov; 64(6):245-8. PubMed ID: 19110967 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema. Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208 [TBL] [Abstract][Full Text] [Related]
25. Device thrombosis in the HeartWare left ventricular assist device. Siddique A; Wrightson N; Macgowan GA; Schueler S Ann Thorac Surg; 2013 Apr; 95(4):1508. PubMed ID: 23522225 [No Abstract] [Full Text] [Related]
26. Reply: To PMID 22734996. Kamouh A; John R; Eckman PM Ann Thorac Surg; 2013 Apr; 95(4):1508-9. PubMed ID: 23522224 [No Abstract] [Full Text] [Related]
27. Significance of microvascular thrombosis in renal allografts: role of ex vivo thrombolytic therapy. Nghiem DD; Olson PR; Sureshkumar KK Clin Transplant; 2007; 21(2):172-6. PubMed ID: 17425741 [TBL] [Abstract][Full Text] [Related]
30. 'STAR' war against coronary thrombosis. Gambhir DS; Gambhir J Indian Heart J; 1995; 47(5):459-60. PubMed ID: 8714497 [No Abstract] [Full Text] [Related]
31. New standard for success of thrombolytic therapy. An earnest proposal. Forrester JS Circulation; 1995 Oct; 92(8):2026-8. PubMed ID: 7554175 [No Abstract] [Full Text] [Related]
32. Viewpoint: megatrials and the development of antithrombotics. Polak M Circulation; 2006 Jun; 113(25):f97. PubMed ID: 16801471 [No Abstract] [Full Text] [Related]
33. Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems. Markland FS Adv Exp Med Biol; 1996; 391():427-38. PubMed ID: 8726081 [No Abstract] [Full Text] [Related]
34. Tissue plasminogen activator does not benefit most eligible patients with stroke. Lansberg MG; Schwartz NE Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946 [No Abstract] [Full Text] [Related]
35. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study). Blaney M; Shen V; Kerner JA; Jacobs BR; Gray S; Armfield J; Semba CP; J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1745-51. PubMed ID: 17142704 [TBL] [Abstract][Full Text] [Related]
36. Prosthetic valve thrombosis: a regimen of treatment with low-dose and longer-course using recombinant tissue-type plasminogen activator is a promising protocol. Cáceres-Lóriga FM; Pérez-López H; Morlans-Hernández K J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1104-5. PubMed ID: 18954672 [No Abstract] [Full Text] [Related]